Brief: BB Biotech AG posts 2018 Loss Of around CHF 471 Million
Jan 18 (Reuters) - BB Biotech AG BION.S :
* SAYS CLOSED ITS FISCAL YEAR 2018 WITH A LOSS OF
APPROXIMATELY
CHF 471 MILLION, BASED ON ITS PRELIMINARY UNAUDITED CONSOLIDATED
RESULTS
Source text for Eikon:
ID:urn:newsml:newsroom:20190118:nNRA7s1b3z:0
Further company coverage: BION.S
(Reporting By Zurich newsroom)
((zurich.newsroom@thomsonreuters.com; +41 58 306 7336;))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM